The Bengaluru-based agritech startup is using extracts from the highly invasive congress grass to develop a crop-shielding ...

High levels of debt obligations have led several biotechnology and pharmaceutical companies into financial distress, requiring them to file for bankruptcy and, in many cases, seek sales of their ...

Home Depot doesn’t expect to raise prices because of tariffs, saying it has spent years diversifying the sources for the ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Chicago’s life sciences market has become the smallest of any major U.S. hub with a vacancy rate of 43.3 percent.

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Being able to adapt to your environment is critical to survival. That’s what Charles Darwin discovered when he developed the ...

The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. | ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...